This review aimed to provide up-to-date evidence for the therapeutic impact of polyphenols via the regulation of the NLRP3 inflammasome pathway, with a focus on pancreatitis, gastrointestinal and liver disorders. This evidence concerns the gene NLRP3 and liver disorder.